Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “a Randomized Double-blind Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06473597
What this trial is testing

A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache

Who this might be right for
Migraine
Antonios Likourezos 80
Large-scale testing (Phase 3)Active Not RecruitingNCT07186413
What this trial is testing

Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris

Who this might be right for
Acne Vulgaris
Galderma R&D 561
Testing effectiveness (Phase 2)Study completedNCT06150924
What this trial is testing

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

Who this might be right for
Chronic Kidney Disease
Mineralys Therapeutics Inc. 60
Not applicableStudy completedNCT00744224
What this trial is testing

PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide

Who this might be right for
Glucocorticoid-induced Glucometabolic AbnormalitiesGlucocorticoid-induced Beta-cell Dysfunction
Amsterdam UMC, location VUmc 8
Large-scale testing (Phase 3)Study completedNCT06048224
What this trial is testing

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Active Rheumatoid Arthritis
Zhejiang Hisun Pharmaceutical Co. Ltd. 669
Not applicableStudy completedNCT03756623
What this trial is testing

Effect of Metformin and Probiotics on Gut Microbiome in Healthy Subjects

Who this might be right for
Healthy
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 90
Not applicableStudy completedNCT01132079
What this trial is testing

Pimecrolimus and Epidermal Barrier Function

Who this might be right for
Atopic Dermatitis
University of Kiel 15
Large-scale testing (Phase 3)Ended earlyNCT01576679
What this trial is testing

Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study

Who this might be right for
Intra-abdominal Abscess
The Hospital for Sick Children 28
Testing effectiveness (Phase 2)Study completedNCT00890162
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis

Who this might be right for
AnaphylaxisHypotensionBronchospasm+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 16
Testing effectiveness (Phase 2)Looking for participantsNCT07077746
What this trial is testing

HB-adMSCs for the Treatment of Crohn's Disease

Who this might be right for
Crohn Disease (CD)
Hope Biosciences Research Foundation 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05126888
What this trial is testing

SCI-110 in the Treatment of Tourette Syndrome

Who this might be right for
Tourette Syndrome
Neurothera Labs Inc. 164
Testing effectiveness (Phase 2)Study completedNCT04620161
What this trial is testing

A Proof of Concept Study of Pradigastat in Patients With Functional Constipation

Who this might be right for
Functional Constipation
Anji Pharma 181
Testing effectiveness (Phase 2)Study completedNCT03304470
What this trial is testing

Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
UNION therapeutics 31
Large-scale testing (Phase 3)Study completedNCT03443869
What this trial is testing

Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)

Who this might be right for
CMV Disease
Merck Sharp & Dohme LLC 601
Not applicableLooking for participantsNCT07441070
What this trial is testing

Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress

Who this might be right for
Minority StressPsychological StressAnxiety
SF Research Institute, Inc. 80
Large-scale testing (Phase 3)Study completedNCT06415773
What this trial is testing

Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Shenzhen HighTide Biopharmaceutical Ltd. 367
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07649369
What this trial is testing

A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion

Who this might be right for
Malignant Pleural Effusions (Mpe)
Shanghai Jeyou Pharmaceutical Co., Ltd. 120
Not applicableEnded earlyNCT03057769
What this trial is testing

Effect of Papillary Epinephrine Spraying on Post-ERCP Pancreatitis in Patients Received Rectal Indomethacin

Who this might be right for
PancreatitisEndoscopic Retrograde Cholangiopancreatography
Air Force Military Medical University, China 3,300
Not applicableStudy completedNCT06037668
What this trial is testing

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.

Who this might be right for
Social Anxiety Disorder (SAD)
Sumitomo Pharma America, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00404768
What this trial is testing

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Who this might be right for
Obstetric Labour, Premature
GlaxoSmithKline 93
Next Page